OakChart

Nortech Systems Inc

NSYSHealthcare·Medical Devices·USA·Nano·NASD·Nov 11 • 3:59 PM ET

10.71+0.02 (0.19%)
2026-11-12 05:23 CET
Market cap
30.56 USD m
Revenue, TTM
124.65 USD m
Net income, TTM
1.03 USD m
Free cash flow, TTM
2.45 USD m
EPS diluted, TTM
0.35
P/E
30.66
Compare

Price

NSYS against its 20, 50 and 200-day averages
2050200earnings
10.0012.0014.0016.0018.0057K114KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NSYSclose 10.7120-day 10.6250-day 11.05200-day 12.3610.7152w high

40.5% under the 52-week high of 18.01 on 2 Jun 2026. 52-week low 6.50 on 13 Nov 2025. Last 15 sessions, 24.2% high to low

Volume 0.08× normal · the line is the 50-bar volume average

Profile

NSYS
52-week range, 37% of the way up
6.5018.01

Nortech Systems, Inc. operates as an electronic manufacturing services company. The firm offers engineering design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies and components. Its manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electromechanical assemblies. The company was founded in December 1990 and is headquartered in Maple Grove, MN.

Employees713
IPOJun 11, 1993
Beta-0.05
ATR, 14d0.63
Rel volume0.08
Short float0.30%
Insider own62.32%
Inst own7.81%

Snapshot

6 groups

Valuation

Index-
Market Cap30.57M
Enterprise Value47.04M
Income1.03M
Sales124.65M
Book/sh12.34
Cash/sh0.59
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees713
IPOJun 11, 1993

Ratios

P/E30.66
Forward P/E-
PEG-
P/S0.25
P/B0.87
P/C18.30
P/FCF12.48
EV/EBITDA12.58
EV/Sales0.38
Quick Ratio1.10
Current Ratio1.78
Debt/Eq0.50
LT Debt/Eq0.23
Option/ShortNo / Yes

Earnings

EPS (ttm)0.35
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y- 31.03%
Sales past 3/5Y-4.08% 2.60%
EPS Y/Y TTM131.69%
Sales Y/Y TTM6.00%
EPS Q/Q-0.47%
Sales Q/Q9.34%
EarningsNov 12 AMC
EPS/Sales Surpr.- -

Ownership

Insider Own62.32%
Insider Trans0.00%
Inst Own7.81%
Inst Trans14.22%
ROA1.33%
ROE3.00%
ROIC2.37%
Gross Margin16.44%
Oper. Margin2.02%
Profit Margin0.83%
SMA200.88%
SMA50-3.12%
SMA200-13.36%
Trades-

Technical

Shs Outstand2.85M
Shs Float1.08M
Short Float0.30%
Short Ratio0.30
Short Interest0.00M
52W High18.01 -40.52%
52W Low6.50 64.77%
Volatility4.18% 5.39%
ATR (14)0.63
RSI (14)48.08
Beta-0.05
Rel Volume0.08
Avg Volume10.84K
Volume835

Performance

Perf Week-1.92%
Perf Month-2.72%
Perf Quarter-16.00%
Perf Half Y-23.28%
Perf YTD44.24%
Perf Year18.60%
Perf 3Y14.06%
Perf 5Y3.98%
Perf 10Y189.46%
Recom-
Target Price-
Prev Close10.69
Price10.71
Change %0.19%

Peers

Mkt cap
TickerCompanyMkt cap
ITGRInteger Holdings Corp4.31B
PLXSPlexus Corp5.65B
BHEBenchmark Electronics Inc2.32B
KEKimball Electronics Inc468.26M
SANMSanmina Corp8.54B
ELMDElectromed Inc206.84M
IRMDIradimed Corp1.11B
JBLJabil Inc26.66B
FLEXFlex Ltd29.18B
LFCRLifecore Biomedical Inc242.60M

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B
DCORUS Core Equity 1 Portfolio ETF Class SharesAUM: 3.65B
DFSUDimensional US Sustainability Core 1 ETFAUM: 2.38B
DXUVUS Vector Equity Portfolio ETF Class SharesAUM: 665.71M
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.14B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q12026-05-13---0.01030.32--
2025Q42026-03-26--0.31030.31--
2025Q32025-11-13---0.05030.48--
2025Q22025-08-07--0.12030.68--
2025Q12025-05-14---0.48026.90--
2024Q42025-03-31---0.54028.62--
2024Q32024-11-07---0.27031.41--
2024Q22024-08-08--0.05033.89--
2024Q12024-05-16--0.26034.22--
2023Q42024-03-20--1.51036.05--
2023Q32023-11-08--0.42033.37--
2023Q22023-08-09--0.22035.02--
2023Q12023-05-10--0.23034.89--
2022Q42023-03-16---0.14035.62--
2022Q32022-11-14--0.53035.28--
2022Q12022-05-11--0.05030.71--

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
No annual earnings.

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual-0.890.062-0.461-0.5822.5360.6952.382-0.47-0.0910.3493
Period201720182019202020212022202320242025TTM
EPS, quarterly0.054-0.268-0.536-0.4770.106-0.0520.309-0.0120.105
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual112.335113.37116.333104.106115.168134.123139.332128.133118.365124.65
Period201720182019202020212022202320242025TTM
Sales, quarterly33.89131.40728.6226.89530.67530.48230.31330.31633.54
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual2.7392.6632.6582.662.6722.6912.6912.7612.7862.854
Period201720182019202020212022202320242025MRQ
Shares, quarterly2.7622.7562.7612.7612.782.7862.7862.7862.854
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue124.65118.36128.13139.33134.12115.17104.11116.33113.37
Cost of Goods Sold Incl. D&A104.16100.36111.41116.23113.6499.3095.65103.76100.06
Gross Profit20.5018.0116.7223.1020.4815.868.4612.5813.31
Selling, General and Administrative Excl. Other17.9816.7716.3517.1516.6112.8510.5212.3512.06
Research and Development1.201.171.191.201.460.48---
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income2.521.240.385.953.873.02-2.060.221.25
Interest Expense0.950.960.740.490.410.430.621.040.76
Unusual Expense0.000.270.570.000.00-5.282.38-0.00
Net Income Before Taxes1.570.01-0.945.473.488.01-1.24-0.820.49
Income Taxes0.540.260.36-1.411.470.860.310.410.33
Consolidated Net Income1.03-0.25-1.296.872.017.15-1.55-1.230.17
Net Income From Continuing Operations1.03-0.25-1.296.872.017.15-1.55-1.230.17
Net Income1.03-0.25-1.296.872.017.15-1.55-1.230.17
EPS (Recurring)0.34-0.02-0.322.380.701.220.04-0.460.06
EPS (Basic, Before Extraordinaries)0.37-0.09-0.472.530.752.68-0.58-0.460.06
EPS (Diluted)0.35-0.09-0.472.380.702.54-0.58-0.460.06
EBITDA3.742.532.118.005.794.970.132.443.44
Non-Operating Income (Expense)0.000.000.000.000.010.143.820.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.430.400.360.200.240.110.050.200.10
Price To Earnings Ratio30.6630.666.6012.894.564.02--56.71
Price To Sales Ratio0.380.170.220.200.260.250.180.110.08
Gross Margin16.4415.2113.0516.5815.2713.778.1210.8111.74
Operating Margin2.021.050.294.272.892.62-1.980.191.10
Net Margin0.83-0.21-1.014.931.506.21-1.49-1.060.15
Shares Outstanding2.852.792.762.692.692.672.662.662.66
Market Capitalization30.5630.5628.3725.8032.9627.6619.0512.949.49

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue33.5430.3230.3130.4830.6826.8928.6231.41
Cost of Goods Sold Incl. D&A27.8425.6125.2525.4625.8423.8225.8027.57
Gross Profit5.704.705.075.034.843.082.823.83
Selling, General and Administrative Excl. Other5.084.664.174.084.094.423.754.13
Research and Development0.350.310.280.270.300.330.300.28
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income0.620.050.900.940.74-1.35-0.92-0.29
Interest Expense0.200.260.220.270.260.210.200.22
Unusual Expense0.000.000.000.000.000.270.300.18
Net Income Before Taxes0.43-0.210.680.670.48-1.83-1.42-0.68
Income Taxes0.11-0.17-0.220.820.17-0.510.060.06
Consolidated Net Income0.32-0.030.90-0.150.31-1.32-1.48-0.74
Net Income From Continuing Operations0.32-0.030.90-0.150.31-1.32-1.48-0.74
Net Income0.32-0.030.90-0.150.31-1.32-1.48-0.74
EPS (Recurring)0.11-0.010.31-0.050.11-0.41-0.46-0.22
EPS (Basic, Before Extraordinaries)0.11-0.010.32-0.050.11-0.48-0.54-0.27
EPS (Diluted)0.11-0.010.31-0.050.11-0.48-0.54-0.27
EBITDA0.940.351.201.251.07-1.00-0.580.14
Non-Operating Income (Expense)0.000.000.000.000.000.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.120.100.110.110.090.090.100.10
Price To Earnings Ratio30.66-----6.607.51
Price To Sales Ratio0.380.280.180.220.220.220.220.24
Gross Margin17.0015.5116.7116.4915.7711.449.8612.21
Operating Margin1.860.162.973.102.42-5.01-3.23-0.93
Net Margin0.94-0.112.96-0.481.02-4.89-5.16-2.35
Shares Outstanding2.852.792.792.792.782.762.762.76
Market Capitalization30.5633.9620.6925.1624.6626.1928.3732.35

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments1.660.921.682.482.233.560.660.950.78
Short Term Receivables32.1828.6733.7628.6128.4521.5226.2226.5217.65
Inventories20.7021.6421.6622.4419.4313.9214.2817.0018.53
Other Current Assets1.624.091.701.331.662.032.131.380.82
Total Current Assets56.1555.3158.7954.8651.7741.0443.2845.8637.77
Net Property, Plant & Equipment12.2214.3713.4314.2614.8215.4214.4110.1810.18
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets0.160.170.260.420.501.173.723.904.11
Deferred Tax Assets3.392.582.64-----0.50
Other Assets0.000.000.000.000.000.000.000.030.01
Total Assets71.9272.4475.1369.5467.0957.6361.4159.9652.57
Short Term Debt Incl. Current Port. of LT Debt8.611.321.391.541.642.551.861.121.30
Accounts Payable12.8111.5815.9214.7912.7111.2414.0118.1411.70
Income Tax Payable--------0.04
Other Current Liabilities8.438.539.2710.067.955.756.365.635.01
Total Current Liabilities29.8421.4326.5826.4022.3119.5422.2324.8918.04
Long Term Debt7.1016.7212.7914.9718.5719.2319.0813.8414.08
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.360.220.24-----0.48
Other Liabilities0.070.070.170.100.100.150.120.140.14
Total Liabilities37.3738.4339.7841.4640.9838.9241.4338.8732.74
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.250.250.250.250.250.250.250.250.25
Common Equity34.3033.7635.0927.8325.8618.4719.7320.8419.58
Total Shareholders Equity34.5534.0135.3428.0826.1118.7219.9821.0919.83
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity34.5534.0135.3428.0826.1118.7219.9821.0919.83
Total Liabilities & Stockholders Equity71.9272.4475.1369.5467.0957.6361.4159.9652.57
Book Value Per Share12.3112.2313.0410.349.686.947.427.837.15
Tangible Book Value Per Share12.2512.1612.9510.199.496.506.026.365.64
Full-Time Employees713701733832807699784819800
Price to Book Ratio0.870.800.851.181.071.030.660.450.48
Return on Assets-0.35-1.769.502.9411.47-2.60-2.020.30-4.49
Return on Equity-0.74-3.7321.687.4231.92-7.99-5.980.81-11.61
Return on Invested Capital-0.61-2.5514.284.6716.01-4.07-3.140.48-7.21
Quick Ratio1.191.571.401.231.451.391.301.161.07
Current Ratio1.882.582.212.082.322.101.951.842.09

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income1.03-0.25-1.296.872.017.15-1.55-1.230.17
Depreciation1.231.291.742.051.921.952.192.222.19
Other Funds (Non Cash)0.280.870.560.470.10-11.58-0.590.780.41
Funds from Operations2.111.350.997.044.03-2.480.061.792.76
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital0.961.40-3.24-5.271.37-2.061.31-0.80-0.32
Income Taxes Payable--0.03-0.33-0.830.640.63-0.680.40-0.04
Cash from Operating Activities3.072.74-2.251.775.40-4.541.361.002.44
Capital Expenditures-0.62-0.66-1.27-1.28-2.44-1.36-0.52-0.76-1.40
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.490.500.010.000.010.636.020.000.01
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.12-0.16-1.26-1.28-2.43-0.735.50-0.76-1.39
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.230.02-0.060.160.050.040.00-0.12-0.28
Repurchase of Common Pref Stock0.000.00-0.100.000.000.000.00-0.13-0.28
Sale of Common Pref Stock0.230.020.040.160.050.040.000.010.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.010.00
Issuance or Reduction of Debt, Net-2.19-1.893.19-1.05-2.723.90-3.96-0.40-0.61
Change in Long Term Debt-2.19-1.893.19-1.05-2.723.90-3.96-0.40-0.61
Issuance of Long Term Debt87.35101.78130.14124.55119.355.696.080.820.76
Reduction of Long Term Debt-89.54-103.67-126.94-125.60-122.07-1.79-10.04-1.23-1.37
Net Financing Active Other Cash Flow0.000.00-0.37-0.390.000.000.000.000.00
Other Financing Activities Uses0.000.00-0.37-0.390.000.000.000.000.00
Cash from Financing Activities-1.95-1.872.77-1.28-2.673.93-3.96-0.53-0.89
Exchange Rate Effect0.030.02-0.01-0.01-0.050.000.00-0.000.00
Net Change in Cash1.020.74-0.76-0.810.26-1.342.90-0.290.17
Free Cash Flow2.452.08-3.520.483.03-5.830.880.281.04
Price to Free Cash Flow19.369.90-56.0511.68-21.7046.699.18
Deferred Taxes & Investment Tax Credit--0.56-0.01-2.360.000.000.000.020.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments1.672.211.661.270.651.16
Short Term Receivables36.8333.8332.1834.1432.7929.07
Inventories24.5123.5620.7018.4318.6320.91
Other Current Assets1.281.071.625.376.246.18
Total Current Assets64.2960.6756.1559.2158.3257.32
Net Property, Plant & Equipment11.4011.8012.2212.6313.0113.41
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.150.150.160.160.170.17
Deferred Tax Assets3.963.753.392.763.272.58
Other Assets0.240.270.000.000.060.06
Total Assets80.0576.6471.9274.7674.8373.53
Short Term Debt Incl. Current Port. of LT Debt9.799.498.6113.591.471.87
Accounts Payable14.9514.6412.8111.6811.9310.06
Other Current Liabilities11.308.878.438.348.218.78
Total Current Liabilities36.0433.0029.8433.6021.6120.72
Long Term Debt8.108.517.107.5119.5419.70
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities--0.36---
Other Liabilities0.430.430.070.290.290.29
Total Liabilities44.5741.9337.3741.4041.4440.70
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.250.250.250.250.250.25
Common Equity35.2234.4634.3033.1133.1432.58
Total Shareholders Equity35.4734.7134.5533.3633.3932.83
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity35.4734.7134.5533.3633.3932.83
Total Liabilities & Stockholders Equity80.0576.6471.9274.7674.8373.53
Book Value Per Share12.3412.3712.3111.8811.9211.80
Tangible Book Value Per Share12.2912.3112.2511.8311.8611.74
Full-Time Employees--713---
Price to Book Ratio0.870.990.620.760.760.78
Return on Assets1.331.37-0.35-3.46-4.26-4.53
Return on Equity3.003.05-0.74-7.61-9.26-9.81
Return on Invested Capital0.73-0.082.15-0.360.59-2.51
Quick Ratio1.101.121.191.211.841.76
Current Ratio1.781.841.881.762.702.77

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income0.32-0.030.90-0.150.31-1.32
Depreciation0.320.300.300.310.330.35
Other Funds (Non Cash)0.09-0.090.160.110.210.38
Funds from Operations0.51-0.180.990.780.16-0.58
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.40-1.384.61-0.870.00-2.35
Cash from Operating Activities-0.89-1.565.61-0.090.16-2.93
Capital Expenditures-0.10-0.23-0.14-0.15-0.10-0.27
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.490.010.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.10-0.23-0.140.34-0.09-0.27
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)---0.00--
Change in Capital Stock0.230.000.000.000.000.02
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.230.000.000.000.000.02
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.202.34-5.080.36-0.593.43
Change in Long Term Debt0.202.34-5.080.36-0.593.43
Issuance of Long Term Debt25.1011.8725.5724.8125.2226.19
Reduction of Long Term Debt-24.90-9.53-30.66-24.45-25.81-22.76
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.442.34-5.080.36-0.593.45
Exchange Rate Effect0.010.010.010.010.01-0.00
Net Change in Cash-0.530.550.380.62-0.510.25
Free Cash Flow-0.98-1.795.46-0.240.06-3.20
Price to Free Cash Flow19.369.7310.37---

Revenue breakdown

Aerospace and Defense2024: 20.49M 2025: 15.50M
Industrial2024: 35.52M 2025: 30.94M
Medical Device2024: 34.64M 2025: 31.93M
Medical Imaging2024: 37.49M 2025: 40.00M
United States2024: 128.13M 2025: 118.37M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.30%0.0M1.1M12.13K
2026-10-150.15%0.0M1.1M14.40K
2026-09-300.13%0.0M1.1M18.99K
2026-09-150.35%0.0M1.1M21.37K
2026-08-310.34%0.0M1.1M22.98K
2026-08-140.75%0.0M1.1M26.39K
2026-07-310.68%0.0M1.1M25.96K
2026-07-150.92%0.0M1.1M27.14K
2026-06-300.99%0.0M1.1M28.03K
2026-06-150.94%0.0M1.1M28.09K
2026-05-291.42%0.0M1.0M24.10K
2026-05-150.17%0.0M1.0M19.76K
2026-04-301.13%0.0M1.0M17.72K
2026-04-151.14%0.0M1.0M14.62K
2026-03-311.22%0.0M0.9M8.47K
2026-03-130.23%0.0M0.9M6.16K
2026-02-270.35%0.0M0.9M5.97K
2026-02-130.61%0.0M0.9M6.05K
2026-01-301.13%0.0M0.9M9.34K
2026-01-150.68%0.0M0.9M8.44K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-09-164Statement of changes in beneficial ownership of securities2026-03-31SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-03-31SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-03-31SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-03-31SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-03-31SEC
2026-08-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-128-KCurrent report2026-08-12SEC
2026-05-20S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-05-18SDSpecialized Disclosure ReportSEC
2026-05-148-KCurrent report2026-05-13SEC
2026-05-138-KCurrent report2026-05-13SEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-1510-K/A2025-12-31SEC
2026-04-01DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-04-01SEC
2026-04-01DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-03-268-KCurrent report2026-03-26SEC
2026-03-2610-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-238-KCurrent report2026-03-20SEC
2026-03-068-KCurrent report2026-02-27SEC
2026-01-068-KCurrent report2026-01-05SEC
2025-11-138-KCurrent report2025-11-13SEC
2025-11-1310-QQuarterly report pursuant to Section 13 or 15(d)2025-09-30SEC
2025-10-278-KCurrent report2025-10-21SEC
2025-08-198-KCurrent report2025-08-18SEC
2025-08-078-KCurrent report2025-08-07SEC
2025-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2025-06-30SEC
2025-08-018-KCurrent report2025-07-29SEC
2025-06-208-KCurrent report2025-06-17SEC
2025-05-224Statement of changes in beneficial ownership of securities2025-05-19SEC
2025-05-224Statement of changes in beneficial ownership of securities2025-05-19SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
WELLS FARGO & COMPANY/MN2.72%
RENAISSANCE TECHNOLOGIES LLC2.24%
VANGUARD CAPITAL MANAGEMENT LLC0.94%
Chevy Chase Trust Holdings, LLC0.57%
Pathstone Holdings, LLC0.43%
DIMENSIONAL FUND ADVISORS LP0.40%
MORGAN STANLEY0.30%
VANGUARD FIDUCIARY TRUST CO0.19%
BlackRock, Inc.0.16%
Larson Financial Group LLC0.01%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND0.59%
VANGUARD EXTENDED MARKET INDEX FUND0.35%
Fidelity Extended Market Index Fund0.17%
U.S. Social Core Equity 2 Portfolio0.13%
iShares Micro-Cap ETF0.12%
Fidelity Series Total Market Index Fund0.06%
U.S. CORE EQUITY 1 PORTFOLIO0.04%
Fidelity Nasdaq Composite Index Fund0.04%
Dimensional US Core Equity 1 ETF0.03%
U.S. VECTOR EQUITY PORTFOLIO0.03%

OakChart. NSYS. Cached 15 minutes.

Some panels did not load: ratings, insider.